V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005428 | 280003471 | 1.67 | 87.4 | Not known (9) | 2017-10-27 | 2017-11-01 | Ifosfamide PVI 1g/m2 14day | 02 | N | 280029076 | CISPLATIN + ETOPOSIDE |
| 280005429 | 280003472 | 1.74 | 68.2 | null | 2017-03-30 | 2017-03-30 | ECF | null | null | 280029082 | GEMCARBO |
| 280005430 | 280003473 | 1.98 | 75 | Disease modification (D) | null | 2013-03-06 | IVADo | null | null | 280029085 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 280005431 | 280003474 | 1.8 | 79.8 | Palliative (P) | 2013-08-22 | 2013-09-02 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280029086 | CAPECITABINE + STREPTOZOCIN |
| 280005432 | 280007840 | 1.59 | 110 | Palliative (P) | 2017-06-18 | 2017-06-21 | Trabectedin | N | N | 280029087 | PEMBROLIZUMAB |
| 280005433 | 280010002 | 1.7 | 53 | Palliative (P) | null | 2015-08-24 | Cisplatin + Doxorubicin | N | N | 280029089 | ECARBOX |
| 280005434 | 280003475 | null | null | Palliative (P) | 2016-04-09 | 2016-05-16 | LANREOTIDE | 02 | Y | 280029090 | CAPECITABINE + OXALIPLATIN |
| 280005435 | 280003475 | 1.86 | 83 | Palliative (P) | 2016-07-26 | 2016-08-05 | Docetaxel+Gemcitabine (no prior RT) | 2 | N | 280029090 | CARBOPLATIN + PEMETREXED |
| 280005436 | 280003475 | 1.63 | 52.3 | Palliative (P) | null | 2017-08-02 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 280029090 | CISPLATIN + ETOPOSIDE |
| 280005437 | 280003476 | 1.86 | 61.7 | Palliative (P) | 2017-08-28 | 2017-08-30 | LIPOSOMAL DOXORUBICIN | 02 | N | 280029094 | ECX |
| 280005438 | 280003476 | 1.58 | 62.4 | Palliative (P) | 2013-03-25 | 2013-04-05 | GEDDIS TRIAL | N | N | 280029094 | OXALIPLATIN + MDG |
| 280005439 | 280003477 | 1.73 | 49 | Not known (9) | 2018-06-21 | 2018-07-01 | EpSSG NRSTS 2005 | N | N | 280029097 | TEMOZOLOMIDE |
| 280005440 | 280007843 | null | 0 | null | 2017-07-15 | 2017-08-23 | Bortezomib + CYCLOPHOSPHAMIDE | 01 | Y | 280029099 | GEMCARBO |
| 280005441 | 280003478 | null | null | Palliative (P) | 2014-05-04 | 2014-05-21 | Folfirinox | N | N | 280029101 | GEMCARBO |
| 280005442 | 280003479 | 1.85 | 72.15 | null | null | 2017-03-03 | Gemcitabine + Capecitabine | N | null | 280029102 | FLUOROURACIL |
| 280005443 | 280003479 | 1.73 | 85 | Disease modification (D) | 2016-01-19 | 2016-01-26 | GemCarbo Days 1+8 | 2 | N | 280029102 | CISPLATIN + ETOPOSIDE |
| 280005444 | 280003480 | 1.86 | 84.3 | null | 2016-11-26 | 2016-11-29 | OCTREOTIDE | 02 | N | 280029106 | GEMCITABINE |
| 280005445 | 280003480 | 1.6 | null | Palliative (P) | 2015-10-26 | 2015-11-08 | Ifosfamide | N | N | 280029106 | FLUOROURACIL |
| 280005446 | 280003480 | 1.63 | 76.8 | Palliative (P) | 2017-04-05 | 2017-04-12 | CARBOPLATIN + GEMCITABINE | N | N | 280029106 | OXALIPLATIN + MDG |
| 280005447 | 280003481 | null | 81.7 | Palliative (P) | 2015-03-15 | 2015-03-16 | Capecitabine + Cisplatin + RT | N | null | 280029109 | EVEROLIMUS |
| 280005448 | 280003481 | 1.8 | 10.45 | Palliative (P) | 2015-09-01 | 2015-09-01 | IVA | 02 | null | 280029109 | FLUOROURACIL |
| 280005449 | 280003482 | 1.62 | 72 | Palliative (P) | 2014-12-16 | 2014-12-22 | DE-ESCALATE TRIAL | N | N | 280029113 | CAPECITABINE + IRINOTECAN |
| 280005450 | 280003482 | 1.76 | null | null | 2016-05-27 | 2016-05-27 | ECX | 02 | N | 280029113 | FLUOROURACIL + MITOMYCIN + RT |
| 280005451 | 280003483 | 1.58 | 83 | Palliative (P) | 2015-04-29 | 2015-04-29 | Cisplatin + Fluorouracil + RT 5day | 2 | N | 280029117 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280005452 | 280003484 | 1.71 | 79.7 | null | 2014-06-13 | 2014-06-19 | Doxorubicin + Olaratumab | N | N | 280029118 | ECX |
| 280005453 | 280007848 | 1.85 | 81.1 | Palliative (P) | 2016-11-29 | 2016-11-29 | Ifosfamide | N | null | 280029119 | CARBOPLATIN + PEMETREXED |
| 280005454 | 280003485 | 1.69 | 65 | Palliative (P) | 2015-04-26 | 2015-04-27 | Cisplatin + Etoposide (3 day) | 01 | N | 280029120 | CAPECITABINE + MITOMYCIN |
| 280005455 | 280007849 | 1.61 | 54.5 | Palliative (P) | 2017-01-27 | 2017-01-30 | Liposomal Doxorubicin (Caelyx) | N | N | 280029121 | LANREOTIDE |
| 280005456 | 280010005 | 1.78 | null | null | 2013-10-18 | 2013-10-28 | STS Rhabdo Rel BERNIE IVADo | N | null | 280029123 | CAPECITABINE + CARBOPLATIN |
| 280005457 | 280003486 | 1.73 | 73 | Curative (C) | 2014-02-04 | 2014-02-13 | Doxorubicin + Olaratumab | 02 | N | 280029124 | CISPLATIN + VINORELBINE |
| 280005458 | 280003486 | 1.77 | 100.4 | Palliative (P) | 2015-10-14 | 2015-10-15 | Capecitabine + Oxaliplatin 21day | 02 | N | 280029124 | CAPECITABINE + OXALIPLATIN |
| 280005459 | 280003487 | null | null | null | 2017-07-11 | 2017-07-13 | BCG Intravesical | 2 | Y | 280029129 | VEMURAFENIB |
| 280005460 | 280003487 | 1.73 | 89 | Palliative (P) | 2014-05-10 | 2014-05-12 | DHAP | 02 | N | 280029129 | CARBOPLATIN + PEMETREXED |
| 280005461 | 280003488 | null | 96.5 | Palliative (P) | null | 2014-07-23 | ADE 10+3+5 | N | N | 280029131 | ECX |
| 280005462 | 280003488 | 1.58 | 75.2 | Palliative (P) | 2014-06-01 | 2015-06-05 | IVA | N | N | 280029131 | DABRAFENIB |
| 280005463 | 280003488 | 1.7 | 75.9 | Palliative (P) | 2017-11-09 | 2017-11-14 | GEMCITABINE | N | N | 280029131 | CAPECITABINE |
| 280005464 | 280003488 | 1.85 | null | null | 2015-04-21 | 2015-05-05 | ECX | N | null | 280029131 | GEMCARBO |
| 280005465 | 280011596 | 1.75 | 74 | Palliative (P) | 2014-12-19 | 2014-12-30 | Cisplatin + Doxorubicin | Y | N | 280029137 | CAPECITABINE + IRINOTECAN |
| 280005466 | 280011596 | 1.68 | 84.3 | Disease modification (D) | 2015-04-21 | 2015-05-04 | EOF | N | N | 280029137 | OXALIPLATIN + MDG |
| 280005467 | 280011980 | 1.5 | 67.1 | Palliative (P) | 2014-11-08 | 2014-11-08 | Capecitabine | N | N | 280029140 | OXALIPLATIN + MDG |
| 280005468 | 280011980 | 1.6 | null | Curative (C) | 2017-01-10 | 2017-01-10 | GEMCITABINE | 02 | N | 280029140 | MITOMYCIN INTRAVESICULAR |
| 280005469 | 280003489 | 1.63 | 65 | Palliative (P) | 2015-04-12 | 2015-04-15 | CHOP R - 21 days | N | N | 280029142 | ECX |
| 280005470 | 280003490 | 1.89 | 71.2 | Palliative (P) | 2018-06-21 | 2018-07-04 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280029145 | CAPECITABINE |
| 280005471 | 280003490 | 1.86 | 55.6 | Palliative (P) | 2015-07-03 | 2015-07-04 | LANREOTIDE | null | null | 280029145 | GEMCITABINE |
| 280005472 | 280003491 | 1.76 | null | null | 2016-02-25 | 2016-02-28 | Mitomycin Intravesical | N | N | 280029147 | DACARBAZINE |
| 280005473 | 280003491 | null | null | Curative (C) | 2016-02-23 | 2016-02-23 | Fluorouricil + Folonic Acid (MdG) | N | N | 280029147 | MITOMYCIN INTRAVESICULAR |
| 280005474 | 280003491 | 1.55 | null | null | 2014-06-18 | 2014-07-18 | DABRAFENIB + TRAMETINIB | 2 | N | 280029147 | GEMCARBO |
| 280005475 | 280003491 | null | 90 | null | null | 2014-01-19 | Ifosfamide | null | null | 280029147 | GEMCITABINE |
| 280005476 | 280003491 | 1.5 | 42.3 | Palliative (P) | 2013-11-21 | 2013-12-06 | Vemurafenib | N | N | 280029147 | OXALIPLATIN + MDG |
| 280005477 | 280003492 | 1.62 | 74.4 | Neo-adjuvant (N) | null | 2017-01-17 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 280029153 | BCG |